AWM
IRWD icon

Avior Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Avior Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26
Closed -$226 – 2989
2024
Q1 		$226 Buy
+26
New +$315 ﹤0.01% 2824
2022
Q2 		– Sell
-39,779
Closed -$500K – 1143
2022
Q1 		$500K Sell
39,779
-7,541
-16% -$86.4K 0.04% 297
2021
Q4 		$551K Buy
47,320
+5,306
+13% +$65.1K 0.05% 313
2021
Q3 		$548K Buy
42,014
+1,995
+5% +$25.8K 0.05% 296
2021
Q2 		$515K Buy
40,019
+7,474
+23% +$85.6K 0.05% 292
2021
Q1 		$363K Sell
32,545
-75
-0.2% -$792 0.04% 342
2020
Q4 		$371K Buy
32,620
+10,640
+48% +$116K 0.05% 320
2020
Q3 		$197K Buy
21,980
+1,370
+7% +$13.6K 0.03% 377
2020
Q2 		$212K Buy
20,610
+3,600
+21% +$36.8K 0.03% 374
2020
Q1 		$171K Buy
+17,010
New +$200K 0.03% 364

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Avior Wealth Management's IRWD Position: Q2 2024 in Review

Avior Wealth Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 26 shares — an estimated $226 sold.

Avior Wealth Management first reported a position in IRWD in Q1 2020 and held it in 10 quarters. The position peaked at $551K in Q4 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • Avior Wealth Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 26 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $226.
  • Avior Wealth Management first reported a position in Ironwood Pharmaceuticals in Q1 2020 and held it in 10 quarters.
  • Avior Wealth Management's Ironwood Pharmaceuticals position peaked at $551K in Q4 2021.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.